Tag: C4 Therapeutics Inc.

Analysts Viewpoint

C4 Therapeutics Inc [CCCC] Chief Business Officer makes an insider sale of 669 shares worth $2107.0.

C4 Therapeutics Inc’s recently made public that its Chief Business Officer Boyle Scott N unloaded Company’s shares for reported $2107.0

Insiders Updates

Chief Business Officer Boyle Scott N sold 669 shares of C4 Therapeutics Inc [CCCC]

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

C4 Therapeutics Inc [CCCC] Records 200-Day SMA of $5.28

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

C4 Therapeutics Inc [CCCC] Stock bought by Insider Salter Malcolm for $54532.0

C4 Therapeutics Inc’s recently made public that its Director Salter Malcolm acquired Company’s shares for reported $54532.0 on Nov 18